Polysacchandes. HIB strains 1482, Madigan (Mad), Eagen (kindly provided by Dr Porter Anderson and Dr David H. Smith of the Department of Pediatrics, University of Rochester, Rochester, N. Y ), Johnson-Yale (Johnson), and Rab were grown in Levinthal media supplemented with 10 rag/liter of NAD and 0.5 g/liter each of CaCI2, MgSO~, and citric acid. The culture was grown at 37°C with high aeration and was stirred up to the late logarithmic-growth phase The cells were harvested by centrifugation, and the paste was suspended in 1.0% Cetavlon, 0.5 M NaCI (-50 g wet weight of cells/liter) and stirred vigorously at 37°C for 2 h (E. C Gotschlich. Unpublished observations ) The suspension was centrifuged at 16,000 g for 2 h at 4°C, and the pellet discarded. The supernate was brought to 25% ethanol, stored overnight at 3-8°C, and then centrifuged at 16,000g for 1 h at 4°C The pellet was discarded, and the supernate brought to 70% ethanol and stored overnight at 3-8°C The precipitate was removed by centrifugation at 2,500 g, at 4°C and washed two times with 95% ethanol. The precipitate was treated first with DNase I and RNAase A followed by pronase and was extracted with cold phenol, pH 7.0, to remove residual protein (40) (41) (42) . The resultant product was dialyzed against 0.1 M CaCI2 and then uhracentrifuged to remove hpopolysaccharlde (LPS), dialyzed exhaustively against double-disnlled water at 3-8°C, and freeze-dried as described (41) . The final yield was ~50 mg of HIB Ps/liter culture fluid Pneumococcus type 3 capsular polysaccharide (Pn 3), manufactured for the National Institutes of Allergy and Infectious Diseases (NIAID) by the Eli Lilly & Co, Indianapolis, Ind. (lot 812346), was kindly provided by Dr James C. Hill of the NIAID, National Institutes of Health (NIH). This Pn 3 preparation contained 50 0% wt'wt uronic acid and had <2.0% protein and nucleic acids
Eschenchza cob K13 Ps was kindly donated by Dr Willie Vann, Bureau of Biologics, Food and Drug Administration
Analytzcal Methods The protein, nucleic acid, moisture, endotoxin (LPS) content of the HIB Ps preparations were assayed as described (42) (43) (44) The polysaccharide contents of the HIB Ps solutions and of the conjugates were measured by the Bial reaction using an HIB Ps sample dried to constant weight over P205 in vacuo at 37°C (45) The hydrazide content of the derivatized proteins and polysaccharides was estimated by the TNBS method and is expressed as mol adipic hydrazide (AH)/mol protein (46, 47) shown as the numerical designation after the carrier (e.g.; Johnson-BSA-33). Briefly, 0.5 ml of the ADH standards or of the unknowns was added to 0 5 ml of a saturated solution of sodium borate equilibrated at room temperature A 0 15-ml aliquot of 3 0% TNBS solution was added to each tube, mixed, and the absorbance was read within 5 mm at 500 nm. The readings obtained with the native protein (usually < 10% of the denvatized protein) were subtracted. The sensitivity of the assay was 5 × 10 -6 tool of ADH The number of AH residues/mol protein is shown as the numerical designation after the carrier.
Hyperzmmune Antlsera. Burro and rabbit HIB typing antisera were prepared in our laboratory and were also obtained from Ms. Leslie Wetterlow, Massachusetts Public Health Biologics Laboratories, Jamaica Plains, Mass and Dr. Lucllle Greenwood, Michigan State Public Health Laboratories, East Lansing, Mich. (10) .
Serologzc Serum HIB anticapsular antibodies were measured by a radiolmmunoassay having a sensitivity of 0.03 #g antibody (Ab)/ml and a reproducibility of ± 10% (12) . Serum complement-dependent bactericidal antibodies were assayed as described using precolostral calf serum as a complement source and the Eagen strain as the target organism (10) . Immunodiffusion analysis employed 1.0% agarose in saline under previously described conditions (41) . Quantitative preeipitin analysis employed 0 2-ml aliquots of the HIB Ps and 0 2 ml of burro 132 HIB immunoglobulin (14.1 mg anti-type b Ab/ml).
HIB PS-Protetn
Conjugates. AH derivatives of BSA, HSA, hemocyanin, and diphtheria toxin (collectively designated AH-protein) with varying degrees of derivatizatlon were prepared (47) (48) (49) . Protein solutions (25 mg/ml) and ADH (3.45 rag/rag protein) were reacted with three different coneentrauons of EDAC (0 1, 0.3, and 0.6 rag/rag protein) The pH of the reaction mixture was maintained at 4.7 ± 0.2 with 0.1 N HC! The reaction proceeded at room temperature for 3 h and the reaction mixtures were dialyzed at 3-8°C with two changes/d against 6 liter of 0 2 M NaCI The albumin and Pn 3 polysaccharide derivatives were then dialyzed against two 6-liter changes of deionized water and freeze-dried. The diphtheria toxin and hemocyanin derivatives were then dialyzed against two changes/d of PBS, sterile-filtered, and stored at 3-8°C. The HIB Ps was activated with CNBr as descrsbed (12, 49, 50) Briefly, a solution of HIB Ps (5.0 mg/ml), equilibrated at 4°C, was rapidly brought to pH 10.5 with 0.1 N NaOH. 100 mg/ml CNBr was added to a final concentration of 0.4 mg/mg polysaccharide, and the pH maintained at 10.5 for 6 rain. Then the reaction mixture was brought to pH 8 5 with 0.5 M NaHCO3, and the CNBr-actlvated HIB Ps added to an equal weight of AH-protem or Pn 3 (50 mg/ml dissolved in 0 5 M NaHCO3). The reaction mixture was tumbled gently overnight at 3-8°C and then centrifuged at 16,000 g, 4°C for 20 ram. The supernate was passed through a CL-4B Sepharose column, 1 5 × 90 cm, that was equihbrated with 0 2 M ammonium acetate. The void-volume fractions were pooled, dialyzed against 0.01 M phosphate-buffered 0.145 M NaCI, pH 7.0, at 3-8°C, and passed through a 045-nm membrane (Nagle Co., Nalgene Labware Div.) and stored at 3-8°C.
Animals. BALB/c, C57BL/6, and general-purpose mice from the NIH colony, weighing Mutagenes~s Assay Three compounds were assayed for their mutagenic and toxicity potential using the assay of Ames et al (51) and McCann et al (52) . Five Salmonella typhzmurzum stratus, TA1535, TA1537, TA1538, TA98, and TA100, were used with and without mouse liver S-9 fraction Undiluted ADH (500 ~g/plate), Johnson-BSA-33 (68.3/~g/plate) and BSA-33 (300 /tg/plate), and fourfold diluttons of each showed no toxicity or mutagenicity at the highest concentrations tested. These assays were kindly performed by Dr E.J. Lazear, Dtvislon of Mutagenesis Research, National Center for Toxicological Research, Food and Drug admimstration
Results
Charactenzatzon ofHIB Ps-Protem Conjugates. The molecular sizes of the HIB Ps, the AH-protein derivatives, and a typical HIB Ps-albumin conjugate, Johnson-BSA-33, is illustrated in a gel filtration using CL-4B Sepharose (Fig. 1) . The AH-BSA showed a major symmetrical component with a partition coefficient (Kd) of 0.71 and a small peak (-5% of the preparation) with a Kd of 0.60. The HIB Ps Johnson showed a symmetrical peak with a Kd of 0.33. Gel filtration of the HIB Ps-protein conjugate, Johnson-BSA-33, showed a new component, with a larger molecular size than either the HIB Ps or the AH-protein derivative, passing unretarded through the column (Kd = 0.00) with both protein and polysaccharide. There was second peak containing 15% of the protein and ~50% of the Hib Ps. Table VII ) and B132 HIB typing serum (center well B) For (A) and (B) well 1 HIB Ps, 0 2 mg/ml, well 2 Johnson-BSA-33, 0.5 mg/ml; well 3. E cob KI3-BSA-29 conjugate, well 4 E cob KI3 polysaccharide, 0 5 mg/ml and the HIB Ps-BSA conjugate ( Fig. 2 B) . There was no precipltin reaction with the AH-BSA alone or with the E. cob K13-BSA-33 conjugate. A single precipitin reaction was observed with the rabbit antisera raised against the Johnson-BSA-33 conjugate, and the HIB Ps, Mad-BSA-33, and E. colt K13-BSA conjugates ( Fig. 2A ). No reaction with the E. colt polysaccharide was observed with either antisera. These observations, using gel filtration in aqueous and dissociating solvents and immunodiffusion, indicate that the HIB Ps and protein are covalently bound. Table I shows the Kd values for the various HIB Ps preparations. The molecular size of the HIB Ps conjugates exceeded that of either component. The ratio of the HIB Ps. to protein in the various conjugates varied from 1.15 (Rab-BSA-29) to 0.16 (Mad-hemocyanin-29). All the HIB Ps-protein conjugates induced serum anti-type b antibodies in general-purpose mice, although a rigorous analysts of their comparative immunogenicity was not carried out. The approximate yield of the conjugate was estimated by comparing the total amount of HIB Ps covalently bound to the protein carrier in the void-volume fractions to that in the lower-molecular-weight fractions after gel filtration through CL-4B Sepharose.
Two conjugates were prepared using AH derivatives of Pn 3 and HIB Ps (Mad-Pn 3-33 and Mad-Mad-12). Both polysaccharide-polysacchande conjugates passed unretarded through the CL-4B Sepharose column.
Effect of Dose upon the Immunogemctty of H I B PS-Protem
ConJugate. In many prehminary experiments involving the three mouse strains used in the following experiments, only an occasional animal responded to injection of purified HIB Ps (R. Schneerson, O. Barrera, C. M. Hardegee, W. B. Habig, and J. B. Robbins. Unpublished observations.). The immunogenicity of the conjugates was characterized by comparing The molecular size of the HIB Ps and HIB Ps-protem conjugates is characterized by their Kd through CL-4B Sepharose (41) . The mare component of the conjugates passed through the column in the void volume and, therefore, had a Kd of 0.00. The ratio of HIB Ps carrier m the conjugates was determined by measurement of the HIB Ps using the Bial reaction and the measurement of protein was determined by the method of Lowry (41, 42) . The yield of conjugate is expressed as the percent of HIB Ps m the conjugate passing unretarded through the CL-4B Sepharose column The number of mol AH resldues/mol protein, as estimated by the TNBS reactton (43), is shown as the numerical designation after the carrier both the percentage of responding recipients and the level of the response compared to the controls. Animals were considered responders if they reacted to immunization with serum anti-type b Ab ~0.15 ~g Ab/ml (estimated to be the protective level in humans) (6) (7) (8) (11) (12) (13) . The outbred general-purpose mice were chosen for these experiments. In a representative experiment, the effect of increasing doses of an HIB Ps-AH-BSA conjugate, Rab-BSA-29, injected 2 wk apart, upon the level of serum anu-type b antibodies 7 d after the last injection was studied (Table II) . Doses of 0 01 and 0.1 ~tg of the Rab-BSA-29 conjugate failed to induce a detectable antibody response. At the 1.0/~g dose, 8/10 animals responded and the geometric mean of the responding animals was 1.5 /xg Ab/ml. A slight increase in immunogenicity was observed with doses of 2.5 and 10/~g. With 2.5 ~tg, 9/10 of the animals responded with a geometric mean of 2.3/~g Ab/ml; with 10 ~tg, 9/10 responded with a geometric mean of 4.0/~g Ab/ml. Based upon these experiments and in consideration of the dosage of HIB Ps used in human infants (6-8, 12, 13, 16), 2.5 /~g was chosen for further studies in mice Table III shows a representative experiment illustrating the effect of repeated immunizations with Madhemocyanin-29 upon the level of serum anti-type b A. Groups of 10 mice were injected with 2.5 btg of the HIB Ps-protein conjugate every 2 wk for a total of three doses. Groups of l0 mice were bled 2 wk after the first immunization and 1 wk after the subsequent immunizations and their sera assayed for HIB Ps antibodies Controls were unimmunized animals or animals injected with HIB Ps alone (data not shown) that were bled concurrently. There was an immune response after the first immunt- (12) Responders are defined as those ammals responding w,th serum HIB Ps Ab >--0.15 #g/ml zation with the HIB Ps-protein conjugate (5/10 responders). The number of responders increased to 8/10 after the second and third injections. The geometric mean Ab level progressively increased from 1.40 #g/ml after the first injection to 2.72 #g/ml and then to 3.26 #g/ml after the second and third immunizations, respectively. There was no detectable serum antibody response among both control groups (saline or HIB Ps alone).
Effects of Repeated Injectzons of HIB Ps-Protem Conjugates m Mtce

Immunogemczty of HIB Ps-Serum Albumm Conjugates m Three Mouse Stratus.
One outbred strain of mice, general-purpose mice from the NIH colony, and two inbred strains, BALB/c and C57BL/6, were injected with various HIB Ps-protein conjugates using a total of two 2.5-#g doses injected subcutaneously at a 2-wk interval. The mice were bled 1 wk after the last injection. All three mouse strains showed at least 70% responders with geometric mean antibody levels from 0.50 to 2.5 pg/ml; individual levels of responders ranged from 0.16 to 19.0 #g/ml (Table IV) . We could not detect any significant difference between the overall type b antibody response in the three mouse strains. experiment, a group of nine general-purpose mice were injected two times with 2.5 #g of Mad-BSA-29 2 wk apart and then bled 1 wk after the last injection. The bactericidal titer to HIB organisms and anti-type b Ab in the preimmune animals were 1/20 and <0.03 #g/ml, respectively. Their postimmune bactericidal titers to HIB organisms and anti-type b Ab levels were 1/525 and 2.50 #g/ml, respectively, in the immunized group and 1/62 and <0.03, respectively, in the controls (P < 0 001). Mice were injected subcutaneously with 2 5 #g HIB Ps-albumin conjugate m 0 I ml saline twice (second injection 2 wk after the first) The antmals were bled I wk after the last rejection and their serum anti-type b anubodies assayed Responders are those ammals with a serum ante-type b antibody content ~ 15 #g/ml * General-purpose mice. BALB/c mtce were subcutaneously rejected with one of the two diphtheria toxm-HIB Ps-protem conjugates or sahne (controls) twice (second injecuon 2 wk after the first) and then bled 7 d after the second rejection. Their sera was assayed for anti-type b anubodms by radloimmunoassay (12) (Table I) were injected into general purpose mice with doses of 0.5 and 2.5/zg HIB Ps/conjugate. The same dose was injected twice into 10 animals 2 wk apart. The mice were bled 1 wk after the last injection. There were no responders detected in all the experimental or the control mice (saline or HIB Ps alone).
Immunogen:aty of HIB Ps-Capsular Polysacchande Conjugates. Two different prepara-
TABLE g
Immunogematy of HIB Ps-D:phthena Toxin Conjugates m BALB/c Mice
Effect of Prtmmg wtth Carrter Proteins upon Anti-Type b Anttbo&es Induced by HIB Ps-
Protem Conjugates. Groups of 10 general-purpose mice were injected with 2.5 ~g of BSA, AH-BSA-20 or AH-BSA-33, or saline. 2 wk later, they were injected with 2.5 ~g of Johnson-BSA-33 conjugate in one experiment, and Mad-BSA-20 in another. The animals were bled 1 wk later. Table VI shows that a priming effect, as defined by an enhanced serum anti-type b A response after injection of the conjugate, was induced by the lightly (P < 0.001) and heavily AH-derivatized preparations (P < 0.01) and by the native BSA (P < 0.001). There was no effect upon the HIB Ps Ab response induced by saline injection.
Immunogemczty of HIB Ps-Protem Con3ugates m Rabb~ts. Groups of three rabbits each were injected each with 35 ~g of Johnson-BSA-33 conjugate emusified in CFA. The controls included the HIB-Ps or the AH-BSA-33 derivative alone, or the two physically mixed together. The animals were reinjected 30 d later with the same preparations emulsified in incomplete Freund's adjuvant. Table VII shows the serum anti-type b Ab at various intervals after the injections. The controls, injected with either HIB Ps, the AH-BSA derivative, or both mixed together yielded little or no increase in serum anti-type b Ab. The three rabbits that received the conjugate in CFA reacted w,th a 1,300-to 76,000-fold increase in anti-type b Ab with postimmune levels ranging from 520 to 4,600/tg anti-type b Ab/ml (P< 0.001).
Not shown are the results of the bactericidal Ab titers of the rabbit sera with the HIB strain Eagen. All preimmune sera had low bactericidal antibody titers ranging from 1/2 to 1/32. The HIB Ps-AH-BSA conjugate in CFA induced post-immune bactericidal titers of 1/1,024 to 1/8,192, whereas, the controls had levels ranging from 1/20 to 1/512 (rabbit 7). Absorption of the postimmune sera with the HIB Ps removed most or all of the bactericidal activity. There are no carboxylic acids or as-yet-detectable terminal aldehyde moieties to form direct covalent linkages with the amino groups of proteins or other potential carriers Further, the phosphodiester bond linking ribitol and ribose is labile at both acidic and basic conditions and at temperatures higher than 37 ° . Accordingly, we used CNBr activation under previously described conditions to create an electrophilic group on the HIB Ps (12, 49, 50) . Although this intermediate HIB Ps product reacts efficiently to form a covalent bond with amino groups such as tyramine (12, 50) , we were unable to form conjugates with several proteins including BSA. It has been reported that some proteins and other macromolecules require a spacer to quantitatively bind to another moiety such as an insoluble carbohydrate (48) . Of the sixcarbon moieties we studied as a spacer, only the ADH consistently provided relatively high yields of convalently bound HIB Ps-protein conjugates. Our initial experiments indicate that ~20 mol of AH/mol of carrier protein provide the most effective substrate for CNBr-activated HIB Ps The AH derivatizauon procedure caused some of the diphtheria toxin and hemocyanin to become insoluble. AH derivatives of bovine and human serum albumins, hemocyanin, diphtheria toxin, and Pn 3, prepared by the water-soluble carbodiimide condensation method, are stable for at least 6 mo and may be stored at 3-8°C. The reaction between these AH derivatives and the CNBr-activated HIB Ps is completed at pH 8.5 at 4°C in 15 h. We estimate that at least 90 percent of the protein is covalently bound to the HIB Ps and that the average HIB Ps:protein ratio of immunogenic conjugates was 0.5-1.5:1. All seven HIB Ps-protein conjugates with these characteristics had similar immunogenicity in three mouse strains. Not shown were the results obtained with one HIB Ps-protein conjugate preparation, Johnson-BSA-33, that had depolymerization of the HIB Ps component during the CNBr-activation step. This conjugate had a Kd of 0.45 (smaller size than original HIB Ps) and an 8.33 ratio of HIB Ps:BSA. This conjugate had similar immunogenicity as the other higher-molecular weight-preparations. This finding suggests that there may be a wide range of molecular sizes and polysaccharide ratios that yield immunogenic polysaccharide-protein conjugates. This method of preparing protein-polysaccharide conjugates has been extended to E. colt K1 and Kla capsular polysaccharides, which have carboxylic acid residues and do not contain phosphodiester bonds (41, 54; and R. Schneerson, O. Barrera, and J. B. Robbins. Unpublished observations.).
Our experiments offer some evidence that the HIB Ps has been converted from a thymic-independent to a thymic-dependent immunogen. This evidence may be summarized as follows: (a) The immunogenicity of the HIB Ps was increased when presented as a covalently bound protein-polysaccharide conjugate. The covalent bond seems to be necessary because the HIB Ps mixed with negatively charged macromolecules to form multiple electrostatic interactions, such as with poly-L-lysine, poly-LLys,Tyr,Ala, or methylated serum albumins, or methylated diphtheria toxin, does not invariably induce serum antibodies after subcutaneous injection of saline solutions into mice or rabbits (41, 54; In contrast, conjugates prepared with the thymic-independent Pn 3 or the HIB Ps itself, though of comparatively high molecular size, failed to induce a serum anti-type b response. This finding is consistent with studies that show that covalent binding of haptens to thymic-independent molecules, such as pneumococcal capsular polysaccharide type 3, confer the immunogenic properties of the carrier molecule to the antigenic components of the conjugate (55, 56) . Although a negative finding, such as the lack of immunogenicity, is difficult to interpret, the experiments with both the Pn 3-HIB Ps and the HIB Ps-HIB conjugates suggest that the molecular size of the conjugates, shown to be directly related to the immunogenicity of polysaccharides, may not be a critical variable of the immunogenicity of these hybrid molecules (40, 42, 43) . Both of these polysaccharide-polysaccharide conjugates had considerably higher molecular-sizing characteristics than the parent molecule, yet they failed to induce serum antibodies. (c) Reinjection of HIB-Ps-protein conjugates induced an increase in both the number of responders and in the total level of anti-type b Ab (booster effect) (57) (58) (59) . (d) Carrier priming, induced by the BSA and AH-BSA derivatives, resulted in an enhanced serum anti-type b antibody response to initial immunization with the conjugate (59) (60) (61) (62) . Further experiments to study the cellular basis for the enhanced immungenicity of the HIB Ps-protein conjugates and the molecular characteristics of the serum antibodies are planned (60, 61) .
In preliminary experiments, the HIB Ps-protein conjugate induced an eightfold increase in anti-type b antibodies with bactericidal activity in young adult primates (Macacafasctcularts). Injection of the purified HIB Ps into this, as well as other, primate species yielded a lesser serum anti-type b antibody response (62; L. Martin and P Anderson. Unpublished data.). Furthermore, the E. cob K1-and K13-protein conjugates induced serum anticapsular polysaccharide antibodies in rabbits and rats, respectively. Experiments are planned to study the comparative immunogenicity of these capsular polysaccharides bonded to different carriers as well as to characterize the reactivity to the carrier protein (60, 61) .
The serum antibodies induced by the HIB Ps-protein conjugates exerted a complement-dependent bactericidal activity that has been associated with immunity against HIB type b diseases (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . The ADH, the AH derivative of BSA, and the HIB Ps-BSA conjugate showed no toxicity or mutagenic activity using an in vitro bacterial assay system (51, 52) . Toxicity tests showed that the lethal dose was > 100 mg/22-to 25-g laboratory mouse (63) . Accordingly, this synthetic approach to prepare capsular polysaecharide-protein conjugates may be considered for clinical investigation. Summary A method is presented for covalently bonding Haemoph~lus mfluenzae type b capsular polysaecharide (HIB Ps) to several proteins. The method is efficient and relies upon the use of adipic dihydrazide as a spacer between the capsular polysaccharide and the carrier protein. In contrast to the poor immunogenicity of the purified HIB Ps in mice and rabbits, the HIB Ps-protein conjugates induced serum anti-type b antibodies having bactericidal activity at levels shown to be protective in humans when low doses were injected subcutaneously in a saline solution. The antibody response in mice was related to the dose of the conjugates, increased with the number of injections, and could be primed by the previous injection of the carrier protein. The HIB Ps-protein conjugates were immunogenic in three different mouse strains. The importance of the carrier molecule for the enhanced immunogenicity of the HIB Ps-protein conjugates was shown by the failure of HIB Ps hybrids prepared with either the homologous polysaccharide or pneumococcus type 3 polysaccharide to induce antibodies in mice Rabbits injected with the HIB Ps-protein conjugates emulsified in Freund's adjuvant produced high levels of serum anti-type b antibodies which induced a bactericidal effect upon H. mfluenzae type b organisms. It is proposed that the HIB Ps component of the polysaccharide protein conjugates has been converted to a thymic-dependent immunogen. This method may be used to prepare protein-polysaccharide conjugates with HIB Ps and other polysaccharides to be considered for human use.
